research use only

Kenpaullone CDK inhibitor

Cat.No.S7917

Kenpaullone (9-Bromopaullone, NSC-664704) is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs). It also inhibit glycogen synthase kinase 3β (GSK3β) with IC50 of 0.23 µM.
Kenpaullone CDK inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 327.18

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 327.18 Formula

C16H11BrN2O

Storage (From the date of receipt)
CAS No. 142273-20-9 Download SDF Storage of Stock Solutions

Synonyms 9-Bromopaullone, NSC-664704 Smiles C1C2=C(C3=CC=CC=C3NC1=O)NC4=C2C=C(C=C4)Br

Solubility

In vitro
Batch:

DMSO : 65 mg/mL ( (198.66 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
GSK-3β [1]
(Cell-free assay)
0.23μM
CDK1/CyclinB [1]
(Cell-free assay)
0.4μM
CDK2/CyclinA [1]
(Cell-free assay)
0.68μM
CDK5/p35 [1]
(Cell-free assay)
0.85μM
CDK2/CyclinE [1]
(Cell-free assay)
7.5μM
ERK2 [1]
(Cell-free assay)
9μM
c-Src [1]
(Cell-free assay)
15μM
Casein Kinase 2 [1]
(Cell-free assay)
20μM
ERK1 [1]
(Cell-free assay)
20μM
In vitro
In HEK-293 cells, phosphorylation of the endogenous GSK3α on Tyr279 is greatly decreased after prolonged incubation with Kenpaullone. Also, the Phosphorylation of the endogenous GSK3β also decreases, although less markedly. This compound also induces the dephosphorylation of both GSK3 isoforms in SH-SY5Y cells and PC12 cells. It (20µM) strongly suppresses the autophosphorylation of GSK3β at Tyr216 in vitro whether GSK3 is expressed in Sf21 cells or in E. coli[2][3].
References

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map